Cardiovascular Drug Reviews
SCOPE. Cardiovascular Drug Reviews provides a medium for
publication of review monographs on new or potential cardiovascular
drugs. The reviews cover the pharmacology, pharmacokinetics,
toxicology, and clinical experience with these drugs. All review
articles are peer reviewed by members of the Editorial Board.
CONTRIBUTORS. Send manuscripts to Alexander Scriabine, M.D.,
Editor-in-Chief, Cardiovascular Drug Reviews Editorial Office,
435 Colonial Road, Guilford, CT 06437, USA (E-mail:
email@example.com) (Fax: 203-458-8428).
Manuscript should be submitted in Microsoft Word as an attachment to
Language. Cardiovascular Drug Reviews is published in
American English (e.g. epinephrine, edema, ischemia, normalized, etc.).
Consult Webster's Dictionary for spelling.
Title Page. The title page should include a concise title,
authors' names and affiliations, and an address to which correspondence
and reprint requests should be sent.
Key Words. List key words for index purposes on a separate
page. Consult Medical Subject Headings, Vol. 40, 1999 published by the
National Institutes of Health (ISSN: 0019-3879).
Running Titles: The running titles should be provided by the
author. The first title should include the first and second authors.
If there are more than two authors, list first author, et al. The
second title should consist of one or two words, preferably drug name or
Abstract. A 200 to 300 word abstract should be included with the
manuscript. Starting with Volume 18 (Year 2000) Cardiovascular Drug
Reviews is publishing abstracts of all review articles on the web
free of charge ().
Figures and Tables. All illustrations should be submitted as an
attachment to e-mail or as one set of glossy prints. These should be
professionally labeled and explanatory legends provided on a separate
page. On the back of each figure affix a label giving the figure
number, author's name, and indicating the top of the figure. The
preferred size for prints is 12.5 x 17.5 cm (5 x 7 inches). Tables
should be typed double spaced, without ruled lines. Color printing is
available for an additional charge.
References. References should be numbered in the text and listed
alphabetically, following the sample formats listed below, and typed
double spaced at the end of the manuscript. Provide all authors names
when fewer than seven; when seven or more list only the first three, et
al. Provide article titles and inclusive pages. Index Medicus
abbreviations should be used for journal titles. Accuracy of reference
data is the responsibility of the author. Sample styles are as follows:
1. Hara H, Toriu N, Shimazawa M. Clinical potential of lomerizine, a
Ca2+ channel blocker as an anti-glaucoma drug: effect on
ocular circulation and retinal neuronal damage. Cardiovasc Drug Revs
2. Hardman JG, Limbird LE, Gilman AG: Goodman & Gilman’s the
pharmacological basis of therapeutics, 10th edition. New
York: McGraw-Hill, 2001:1-2148.
Chapter in Book
3. Evers As, Crowder CM. General anesthetics. In: Goodman &
Gilman’s the pharmacological basis of therapeutics, 10th
edition. New York: McGraw-Hill, 2001:337-365.
Style Manuals. Cardiovascular Drug Reviews is using the
following style manuals:
1. Scientific Style and Format. The CBE Manual for Authors, Editors,
and Publishers. Sixth Edition. Published by Cambridge University Press
for Council of Biology Editors, Inc., Chicago, IL, 1994.
2. List of Journals Indexed in Index Medicus. National Library of
PROOFS AND REPRINTS.
Proofs must be returned within 3 days of receipt; late return may cause
a delay in publication. Please check text, tables, legends, and
references very carefully. To expedite publication page proofs rather
than galleys will be sent to authors, and it may, therefore, be
necessary to charge for alterations other than correction of printer's
errors. Return proofs by fax (203-458-8428) or return the pdf file with
notes attached by e-mail (firstname.lastname@example.org).
Manuscripts of 15 or fewer printed pages are published with no page
charge. For longer manuscripts there is a charge of $100.00 per printed
page over 15.
authors should avoid the use of previously published Figures and
Tables. If such use is unavoidable, the author(s) should obtain written
permission to use such material from publishers of the journals where it
may have been published and provide Neva Press, Inc. with copies of the
permissions, which should include electronic and translation rights.
Copyrights on all published articles will be held by the publisher, Neva
Press. In view of present U.S. copyright law, effective January 1,
1978, it is necessary that each author of a submitted manuscript sign a
statement expressly transferring copyright in the event the paper is
published in the journal. After a manuscript has been accepted for
publication, the Editorial Office will send a copyright transfer form to
the corresponding author. It is the responsibility of authors to obtain
permission to reproduce (in printed and electronic formats) for any
figures and tables, which were published previously. This permission
should be obtained from the authors and publishers who own the
Return assignment of
copyright and reprint order forms to Cardiovascular Drug Reviews,
Neva Press, P.O. Box 347, Branford, CT 06405, USA.